Clinical Trials
4 trialsNCT06739252 2026-01-28
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
Peking University
Phase 2 Terminated
NCT04425070 2026-01-05
TOUCH
Antengene Corporation
Phase 1/2 Terminated
NCT00674206 2013-12-12
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer
Emory University
Phase 2 Terminated
NCT00127595 2005-08-24
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Terminated